AIM
LLY icon

Artemis Investment Management’s Eli Lilly LLY Stock Holding History

Artemis Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.4M Buy
92,854
+6,138
+7% +$6.22M 0.91% 38
2025
Q4 		$93.2M Buy
86,716
+49,555
+133% +$47.4M 1.13% 26
2025
Q3 		$28.4M Sell
37,161
-34,936
-48% -$26M 0.35% 90
2025
Q2 		$56.2M Sell
72,097
-2,971
-4% -$2.31M 0.72% 44
2025
Q1 		$62M Buy
75,068
+14,758
+24% +$12.3M 0.95% 36
2024
Q4 		$46.6M Buy
60,310
+4,836
+9% +$4M 0.66% 52
2024
Q3 		$49.1M Buy
55,474
+12,769
+30% +$11.5M 0.75% 38
2024
Q2 		$38.7M Sell
42,705
-23,173
-35% -$18.5M 0.52% 59
2024
Q1 		$51.2M Sell
65,878
-745
-1% -$530K 0.65% 48
2023
Q4 		$38.8M Sell
66,623
-39,479
-37% -$23M 0.56% 59
2023
Q3 		$57M Sell
106,102
-9,689
-8% -$4.99M 0.79% 40
2023
Q2 		$54.2M Buy
+115,791
New +$48.6M 0.68% 48
2022
Q2 		– Sell
-95,026
Closed -$27.2M – 273
2022
Q1 		$27.2M Buy
+95,026
New +$24.5M 0.22% 123
2020
Q4 		– Sell
-38,214
Closed -$5.65M – 280
2020
Q3 		$5.65M Sell
38,214
-2,975
-7% -$460K 0.07% 207
2020
Q2 		$6.78M Buy
41,189
+14,271
+53% +$2.19M 0.09% 197
2020
Q1 		$3.73K Buy
+26,918
New +$3.7M 0.01% 187
2019
Q1 		– Sell
-197,851
Closed -$22.9M – 290
2018
Q4 		$22.9M Sell
197,851
-158,057
-44% -$17.7M 0.3% 101
2018
Q3 		$38.2M Buy
355,908
+98,108
+38% +$9.81M 0.42% 62
2018
Q2 		$22M Buy
+257,800
New +$21.2M 0.3% 87
2015
Q4 		– Sell
-135,094
Closed -$11.3M – 235
2015
Q3 		$11.3M Buy
135,094
+59,453
+79% +$5.02M 0.33% 76
2015
Q2 		$6.31M Buy
+75,641
New +$5.76M 0.2% 112

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artemis Investment Management's LLY Position: Q1 2026 in Review

Artemis Investment Management increased its Eli Lilly (LLY) stake by 7.1% in Q1 2026, buying an estimated $6.22M and bringing the position to 92,854 shares worth $85.4M. The position accounts for 0.91% of the portfolio, ranked #38.

Artemis Investment Management first reported a position in LLY in Q2 2015 and has held it in 21 quarters since. The position peaked at $93.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Artemis Investment Management held 92,854 shares of Eli Lilly worth $85.4M as of Q1 2026.
  • Artemis Investment Management bought 6,138 Eli Lilly shares in Q1 2026, an estimated $6.22M.
  • Eli Lilly made up 0.91% of Artemis Investment Management's portfolio in Q1 2026, its #38 holding.
  • Artemis Investment Management first reported a position in Eli Lilly in Q2 2015 and has held it in 21 quarters since.
  • Artemis Investment Management's Eli Lilly position peaked at $93.2M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Artemis Investment Management's 13F filing for Q1 2026, filed 13 Apr 2026.